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PURPOSE. To study the dynamics of the long (L)- and middle
(M)-wavelength–sensitive cone-driven pathways and their in-
teractions in patients with Stargardt’s macular dystrophy-fun-
dus flavimaculatus (SMD-FF) and to correlate them with other
clinical parameters and individual genotypes.
METHODS. Forty-seven patients with SMD-FF participated in the
study. In addition to standard 30-Hz flicker electroretinograms
(30-Hz fERG), ERG responses were measured to stimuli that
modulated exclusively the L or the M cones (L/M cones) or the
two simultaneously. Blood samples were screened for muta-
tions in the 50 exons of the ABCA4 gene.
RESULTS. Patients with SMD-FF did not show a decrease in the
mean L/M-cone–driven ERG sensitivity, but there was a signif-
icant increase in the interindividual variability. The mean L-/M-
cone weighting ratio was normal. However, the L-cone–driven
ERG was significantly phase delayed, whereas the M-cone–
driven ERG was significantly phase advanced. These phase
changes were significantly correlated with disease duration.
The amplitude and implicit time of the standard 30-Hz fERG
both correlated significantly with the L/M-cone–driven ERG
sensitivity and with the phase difference between the L/M-
cone–driven ERGs, indicating the complex origin of the stan-
dard 30-Hz fERG. Probable disease-associated mutations in the
ABCA4 gene were found in 40 of 45 patients, suggesting that
they form a genetically fairly uniform SMD-FF study group.
There was no correlation between the genotype and the L/M-
cone–driven ERGs.
CONCLUSIONS. The changes in L/M-cone–driven ERG sensitivity
and phase possibly represent two independent disease pro-
cesses. The phase changes are similar to those found in pa-
tients with retinitis pigmentosa and possibly are a general
feature of retinal dystrophies. (Invest Ophthalmol Vis Sci.
2001;42:1380–1389)
Stargardt’s macular dystrophy (SMD) including fundus flavi-maculatus (FF) is one of the most frequent causes of early
macular degeneration and accounts for 7% of all retinal dystro-
phies.1 It is an autosomal recessive condition characterized by
a bilateral loss of central vision occurring early in life. Stargardt
first described the disease as a unique macular dystrophy char-
acterized by visual loss in the first two decades of life in
combination with an atrophic lesion of the macula.2 The term
fundus flavimaculatus was first used by Franceschetti and de-
notes a retinal dystrophy characterized by yellow flecks found
in the distal retina at the posterior pole of the eye.3 Recently,
it has been shown by linkage analysis that SMD and FF are the
same disorder genetically.4
Mutations in the gene ABCA4, which encodes the photore-
ceptor-specific, adenosine triphosphate (ATP)-binding cassette
transporter ABCA4, are responsible for SMD-FF.5,6 Originally, it
was found that ABCA4 was expressed in rods, but not in cone
photoreceptors,5 which was surprising, because SMD-FF in-
volves symptoms mostly related to cone dysfunction.7,8 Re-
cently, it was shown by immunofluorescence microscopy and
Western blot analysis that ABCA4 is present in foveal and
peripheral cones, as well as in rod photoreceptors, and that the
cone-related dysfunctions are a direct consequence of ABCA4-
mediated cone degeneration.9 However, a morphologic differ-
entiation between L- and M-cones was not possible.
We have developed a stimulus technique that allows the
study of the long (L)- and middle (M)-wavelength–sensitive
cone pathways and their interactions functionally by means of
the electroretinogram (ERG).10–12 This technique has been
used to investigate the L- and M-cone (L/M-cone)–driven ERGs
in patients with retinitis pigmentosa (RP), a retinal disorder in
which the primary defect is located within the rod photore-
ceptors.13 We found that the ERG sensitivity for both the L- and
M-cone–driven ERGs was reduced and that there were large
phase differences between the two. It is not evident what
changes in the L/M-cone–driven ERGs occur when the cone
system is thought to be primarily involved, as in SMD-FF. It was
the purpose of the present study to investigate in detail L- and
M-cone functions and their interactions in a large set of patients
with SMD-FF and to correlate these findings with clinical fea-
tures, genotype, and standard ERG techniques in a multidisci-
plinary approach.
METHODS
Patients with SMD-FF and Normal Subjects
Forty-seven patients (age range, 13–59 years; mean, 32.9) participated
in the study. A detailed history (including family history), visual acuity,
visual fields (Tu¨bingen automated perimeter; Oculus Optikgera¨te,
GmbH, Wetzlar, Germany), ganzfeld electroretinography according to
the International Society for Clinical Electrophysiology of Vision
(ISCEV) standard14 (including the standard photopic 30-Hz-flicker ERG
[30-Hz-fERG]), and multifocal electroretinography15 were recorded
and formed the basis for the diagnosis of SMD-FF. Color vision was
screened in 43 patients by the Lanthony D-15 desaturated test.16 This
arrangement test allows a semiquantitative evaluation of color vision
disorders. A discrimination between protan and deutan color vision
deficiencies is virtually impossible, whereas a discrimination between
tritan and protan-deutan deficiencies is easily achieved. We described
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the results of this arrangement test by a categorization scheme from
normal (no error), insignificant (one or more adjacent tablets con-
fused), significant (two confusions between nonadjacent tablets), very
significant (numerous confusions along one major axis: protan, deutan,
or tritan), chaotic, and arrangements not feasible (because the patient
was not able to discriminate any differences in color).17
Fundus appearances were assessed by slit lamp biomicroscopy and
color fundus photographs. In the literature, there is no uniform clas-
sification of the fundus changes in SMD-FF. We staged the central
fundus changes from mild (normal to diffuse foveal reflex, subtle
pigment mottling of the macular retinal pigment epithelium [RPE],
tapetal sheen or beaten-bronze reflex), moderate (pronounced hyper-
and hypopigmentations of the macular RPE, bull’s-eye pigment appear-
ance, choroidal atrophic areas not larger than the typical fundus flecks)
to severe (larger areas of choroidal atrophy). In addition, the existence
and distribution of the typical white-yellow flecks at the level of the
RPE and/or the choroidal atrophy were staged (scoring: 2, no flecks
and choroidal atrophy; 1, flecks and choroidal atrophy confined to the
posterior pole, i.e., within the vascular arcades; and 11, peripheral
flecks and choroidal atrophy extending beyond the vascular arcades).
Recently, the distribution of the fundus flecks has been similarly
classified.18 A summary of the findings in all 47 patients with SMD-FF
is given in Table 1.
Twenty-nine normal subjects (age range, 9–57 years; mean, 29.2)
served as a control. The age of the subjects in each population did not
differ significantly (unpaired t-test). More detailed ERG data on a
TABLE 1. Characteristics of the Patients with SMD-FF
Patient Sex
Age
(y)
Age at
Onset (y) VA CFC DF CV
Exon
(1) Mut (1)
Exon
(2) Mut (2)
1 M 32 29 0.6 Moderate 1 Normal 48 L2241V NF
2 F 39 23 0.4 Moderate 2 Chaotic 14 W663X 42 G1961E
3 M 34 16 0.1 Moderate 1 — 42 G1961E NF
4 M 49 17 0.1 Severe 1 NP 6 G768T/splice 42 G1961E
5 F 36 35 0.6 Moderate 1 VS (T) 6 C230S 42 G1961E
6 M 28 17 0.1 Mild 11 INS 40 R1898H 43 G1975R
7 M 20 9 0.05 Moderate 11 VS (P/D) 12 1 21 L541P 1 A1038V 40 IVS40 1 5G 3 A
8 M 33 6 0.1 Mild 2 Chaotic NF NF
9 M 39 29 0.2 Moderate 1 VS (P/D) 13 G607R 42 G1961E
10 M 38 22 0.1 Severe 1 Chaotic NF NF
11 F 28 20 0.7 Mild 11 INS 3 A60T 40 R1898H
12 M 46 30 0.5 Mild 1 Chaotic 11 E471K 42 G1961E
13 F 25 11 0.1 Moderate 11 S 17 G863A NF
14 F 51 41 0.8 Moderate 11 NP 40 R1898H NF
15 F 23 17 0.1 Mild 2 Chaotic 3 P68L 36 S1689P
16 F 33 30 0.4 Mild 2 Chaotic 28 E1399K 42 G1961E
17 F 41 36 0.1 Severe 1 VS (T) 29 F1440V 37 G1748R
18 M 59 54 0.1 Severe 1 VS (P/D) 42 G1961E NF
19* M 35 15 0.05 Moderate 1 Chaotic 17 G863A 37 Q1750X
20* M 43 14 HM Severe 11 NP 17 G863A 37 Q1750X
21 F 46 16 0.1 Moderate 1 NP NF NF
22 F 32 22 0.05 Moderate 1 INS 21 A1038V NF
23 M 50 42 0.3 Severe 11 VS (P/D) 12 1 21 L541P 1 A1038V 17 G863A
24 F 30 14 0.1 Moderate 11 INS 17 G863A 40 IVS40 1 5G 3 A
25 M 36 25 0.5 Moderate 11 — 3 296INSA 21 A1038V
26 M 40 23 0.2 Moderate 1 S 3 296INSA 42 G1961E
27 F 35 9 0.1 Severe 11 VS (P/D) 22 R1108C NF
28 F 23 18 0.05 Mild 11 S 28 E1399K 43 G1977S
29 F 25 18 0.2 Mild 1 Chaotic 37 L1763P NF
30 F 16 11 0.1 Moderate 1 Chaotic 22 R1108C NF
31 M 40 35 0.1 Moderate 11 VS (P/D) 14 R681X NF
32 F 28 27 0.1 Moderate 1 S 12 1 21 L541P 1 A1038V 21 A1038V
33 M 32 9 0.05 Severe 11 Chaotic 28 Q1412X 45 R2077W
34 F 23 21 0.2 Moderate 1 INS 6 G768T/splice NF
35 F 38 33 FC Moderate 2 Chaotic 17 G863A NF
36 F 39 10 HM Severe 11 NP NF NF
37 F 13 8 0.1 Moderate 11 S — —
38 F 27 25 0.2 Moderate 1 Chaotic 17 G863A 28 Q1412X
39 M 16 15 0.1 Moderate 1 VS (P/D) 12 1 17 R572Q 1 G863A 35 IVS35 1 2T 3 A
40 M 27 26 0.6 Moderate 2 S 17 G863A NF
41 M 18 16 0.2 Moderate 1 — — —
42 M 25 24 0.1 Mild 2 — NF NF
43 F 29 9 0.1 Moderate 1 Chaotic 12 1 21 L541P 1 A1038V 42 G1961E
44 M 39 28 0.1 Mild 2 NP 6 N247S NF
45 F 23 12 0.05 Mild 2 NP 6 R212C 19 T959I
46 M 43 36 0.2 Moderate 1 VS (P/D) 21 A1038V NF
47 M 21 18 0.4 Mild 11 INS 28 Q1412X NF
Shown are age at examination, age of onset, visual acuity, central fundus changes, and existence and distribution of the typical white-yellow
flecks. In addition, the score from the Lanthony D-15 desaturated test (CV) and the molecular genetic findings in the ABCA4 gene are specified
(patients 37 and 41 were not screened for mutations in the ABCA4 gene). VA, visual acuity; CFC, central fundus changes; DF, distribution of flecks;
CV, color vision; FC, visual acuity dropped to finger counting; HM, visual acuity dropped to hand motions; CV test results: INS, insignificant; S,
significant; VS, very significant; T, tritan; P/D, protan/deutan; NP, not possible; NF, not found.
* Patient 19 and 20 were siblings.
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subpopulation of the normal subjects have been published pre-
viously.10 Informed consent was obtained from all subjects after ex-
planation of the purpose and possible consequences of the study. The
study was conducted in accordance with the tenets of the Declaration
of Helsinki and with the approval of our institutional ethics committee
on human experimentation.
ERG Recording
The method of ERG recording has been described before.10,11 Briefly,
the stimuli were presented on a computer-controlled monitor (Barco
CCID 121; Vartech, Baton Rouge, LA) driven at 100 Hz by a graphics
card (VSG 2/3; Cambridge Research Systems, Rochester, UK). The
monitor subtended 124° by 108° at the 10-cm viewing distance. We
used a 30-Hz square-wave modulation of the red, green, and blue
phosphor with predefined Michelson contrasts. The time-averaged
luminance of the monitor was 66 candelas (cd)/m2 (40 cd/m2 for the
green phosphor, 20 cd/m2 for the red phosphor, and 6 cd/m2 for the
blue phosphor). The time-averaged chromaticity in International Com-
mission on Illumination (CIE; 1964) large-field coordinates was: x 5
0.3329, y 5 0.3181. The excitation in each cone type by the monitor
phosphors was calculated by multiplying the phosphor emission spec-
tra with the psychophysically based fundamentals.19
The modulation of cone excitation was quantified by the Michelson
cone contrast and defined the stimulus strength for each cone type
separately. The short (S)-wavelength cones were silently substituted in
all conditions (S-cone contrast was 0%). In 10 of the 47 patients with
SMD-FF and 19 of the 29 normal subjects, we measured ERG responses
to 32 different stimuli: eight conditions of different L-/M-cone contrast
ratios (1:1, 21:1, 1:2, 0:1, 2:1, 22:1, 21:2, and 1:0) with four contrasts
at each condition (100%, 75%, 50%, and 25% of the maximally possible
cone contrast). An L-/M-cone contrast ratio of 1:1 corresponds to an
in-phase modulation of the L/M cones with equal cone contrast; an
L-/M-cone contrast ratio of 21:1 corresponds to a modulation of the
two cone types in counterphase with equal cone contrast; an L-/M-
cone contrast ratio of 1:2 corresponds to an in-phase modulation of the
two cone types with the M-cone contrast twice as much as the L-cone
contrast; and an L-/M-cone contrast ratio of 0:1 corresponds to a silent
substitution of the L cones. In 35 of the 47 patients with SMD-FF and
in 10 of the 29 normal subjects, we limited the measurements to the
four most important conditions with L-/M-cone contrast ratios of 1:1,
1:0, 0:1, and 21:1, which allowed us to obtain reliable amplitude data
and, simultaneously, direct measurements of response phases to cone-
isolating stimuli. In patient 7, five conditions were used; in patient 5,
only ERG measurements to the cone-isolating conditions were per-
formed.
ERG recordings were obtained from one eye in all subjects. Because
SMD-FF usually affects both eyes rather homogeneously, one eye was
randomly chosen (in both subject groups). The pupils of the control
subjects’ eyes were dilated with 0.5% tropicamide, and those of the
patients’ eyes with both 0.5% tropicamide and 5% phenylephrine. The
pupil diameter was recorded before each experiment. There was no
significant difference in pupil diameter between the two subject
groups. The eyes were kept light-adapted for at least 10 minutes before
the ERG recording.
Corneal ERG responses were measured with DTL fiber electrodes
that were positioned on the conjunctiva directly beneath the cornea
and attached with their two ends at the lateral and nasal canthus. The
reference and skin electrodes (gold cup electrodes) were attached to
the ipsilateral temple and the forehead, respectively. The signals were
amplified and filtered between 1 and 300 Hz (Grass, Quincy, MA) and
sampled at 1000 Hz with a data acquisition card (AT-MIO-16DE-10;
National Instruments, Austin, TX). ERG responses to 12 runs, each
lasting 4 seconds, were averaged in each measurement. The ERG
response amplitudes and phases were extracted from a discrete Fou-
rier transform (DFT) of the responses and were defined as the ampli-
tudes and phases of the fundamental component.
Mutation Analysis in the ABCA4 Gene
Forty-five of the 47 patients who participated in the study were
screened for alterations in the ABCA4 gene. DNA was extracted from
peripheral blood according to standard protocols. All 50 exons of the
ABCA4 gene were analyzed by a combination of denaturing gradient
gel electrophoresis (DGGE), denaturing high-performance liquid chro-
matography (DHPLC), and single-strand conformation polymorphism
(SSCP) analysis as described in detail elsewhere.6 Briefly, each exon
was subjected to polymerase chain reaction (PCR) amplification with
oligonucleotide primers designed to amplify the coding region and
splice junctions. For DGGE, the PCR products were electrophoresed
on a 6% polyacrylamide gel containing a 20% to 70% (exons 1, 3, 4, 6,
7, 9, 12–16, 18–26, 28, 29, 31, 33, 25–37, 39–43, 45–48, and 50) or 0%
to 70% (exons 2, 5, 17, 32, and 34) gradient of urea and formamide. To
optimize the sensitivity in mutation detection, the PCR products cor-
responding to exons 8, 27, 30, 38, 44, and 49 were also subjected to
DHPLC.20 For SSCP (exons 10 and 11), the PCR-amplified fragments
were analyzed on a 6% nondenaturing polyacrylamide gel with 5%
glycerol at 4°C. For each technique used, all aberrant fragments were
directly DNA sequenced by using a kit (PRISM Ready Reaction Se-
quencing Kit; Perkin Elmer–Cetus, Norwalk, CT) and an automated
sequencer (AB310; Perkin Elmer–Applied Biosystems, Foster City, CA).
RESULTS
ERG Responses and Model Fits
In Figure 1 original ERG tracings of a patient with SMD-FF
(thick line) and a normal subject (thin line) are shown to a
standard 30-Hz-flicker (ganzfeld; Fig. 1A), to pure L-cone mod-
ulation (Fig. 1B), and to pure M-cone modulation (Fig. 1C).
Patient 25 exhibited mild clinical changes, and the genetic
analysis revealed a 296insA mutation in exon 3 and an A1038V
mutation in exon 21 (Table 1). His ganzfeld white 30-Hz-fERG
signal was reduced in amplitude and somewhat advanced (Fig.
1A). His L-cone–driven ERG signal displayed only minimal
differences in comparison with the normal subject (Fig. 1B),
whereas his M-cone–driven ERG signal was considerably phase
advanced and lower in amplitude (Fig. 1C).
In Figure 2, the mean response amplitudes of normal sub-
jects and patients in the L/M-cone–isolating conditions are
displayed as a function of cone contrast. The relationship
between ERG response amplitude and cone contrast was close
to linear in all conditions and in both the patients with SMD-FF
and the normal subjects (Fig. 2).
The slope of the linear regression of the data is the increase
in ERG amplitude per percentage increase in cone contrast.
This slope was used to define the cone contrast gain. The
inverse of the cone contrast gain is the increase in cone
contrast needed for a 1-mV response increase,10 which, owing
to the linear relationship between amplitude and cone con-
trast, is equivalent to a threshold. The cone contrast gains and
the thresholds were obtained for all ratios of L-/M-cone con-
trasts.
Figure 3A shows the measured ERG thresholds for three
normal subjects. The ellipses are fits of a model, based on the
assumption that the signals originating in the L- and M-cones
are vector summed in the total ERG response. A detailed
description of the model can be found elsewhere.10 Briefly, we
assume that the signals originating in the L/M cones have
separate weightings (defined by the cone contrast gains) and
phases and that the total response is simply the addition of the
two separate responses at each instant. Because the responses
are basically sinusoidal in shape without intrusion of higher
harmonics (see also Reference 12), they can be expressed as
vectors, the lengths of which are determined by the ampli-
tudes. The angles formed with the positive x-axis are equiva-
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lent to the phases. According to this assumption, the response
vector to a combination of L/M-cone modulation is equal to the
addition of the two vectors derived from the responses driven
by each cone. In the fits of this model to the threshold data,
there are three free parameters: the L-cone weighting or L-cone
contrast gain (AL), the M-cone weighting or the M-cone con-
trast gain (AM), and the phase difference between the L- and
M-cone–driven responses (uPL 2 PMu).
As has been reported previously in normal subjects10 and in
patients with RP,13 there is a considerable interindividual vari-
ability of the L-/M-cone weighting ratio reflected by the differ-
ent orientations of the ellipses. The larger the L-/M-cone
weighting ratio, the more the thresholds’ ellipses are tilted
toward the M-cone axis. This variability can be correlated with
variations in the L-/M-cone weighting ratios in psychophysical
tasks that tap the luminance channel and probably can be
attributed to the variability in the number of L and M cones in
the human retina.21,22 Despite the variability, the major axes of
the ellipses of all normal subjects are located within the second
and fourth quadrants, indicating additive interactions between
the signal originating in the L and M cones and that the phase
difference uPL 2 PMuis always smaller than 90° in the normal
subjects.
Figure 3B shows the ERG thresholds for nine patients with
SMD-FF. There is also a considerable interindividual variability
of the L-/M-cone contrast gain ratio. However, we encountered
patients who displayed additive interactions between the L/M-
cone–driven ERGs (Fig. 3B, upper row), but also patients for
whom the cone-driven signals were more or less independent
(Fig. 3B, middle row) or subtractive (Fig. 3B, lower row). As a
result, the phase differences could be smaller than 90° (addi-
tive interactions), approximately orthogonal (independent ac-
tions), or larger than 90° (subtractive interactions). Thus, the
variability in phase difference was considerably larger than in
the normal subjects.
Cone Weightings and ERG Sensitivity
The L-/M-cone weightings (AL and AM, respectively) estimated
from the model fits to the threshold data were statistically
analyzed with an analysis of variance (ANOVA). The ANOVA
revealed that the cone weightings differed significantly in the
groups defined by subject group and cone type (P , 0.0001;
F 5 36.46). Post hoc tests for subsequent multiple compari-
sons between subject groups and cone type, using Tukey–
Kramer’s honestly significant difference (HSD; a 5 0.05), re-
vealed that the average AL of the normal subjects (0.293) was
significantly larger than the average AM (0.112). Similarly, in
the patients AL (0.292) was significantly larger than AM (0.088).
However, AL and AM did not differ between the subject groups
(Fig. 4A).
From the cone weightings we calculated the individual
L-/M-cone weighting ratios (Fig. 4B). These ratios do not have
FIGURE 2. ERG response amplitude to cone-isolating stimuli as a func-
tion of cone contrast in normal subjects and patients with SMD-FF
(mean 6 SD). The data show that there is a linear relationship between
ERG response amplitude and cone contrast. The slopes of the linear
regressions are equivalent to the cone contrast gain. The linear regres-
sions of the L-cone–driven ERG could be described by f(x) 5 20.1 1
0.26 z x for the control group and f(x) 5 0.1 1 0.27 z x for the SMD-FF
group. The linear regressions of the M-cone–driven ERG could be
described by f(x) 5 0.5 1 0.07 z x for the control group and f(x) 5 0.4
1 0.06 z x for the SMD-FF group.
FIGURE 1. Averaged standard 30-Hz-fERG responses (ganzfeld; A) and
ERG responses to pure L-cone (B) and M-cone modulation (C) in a
patient with SMD-FF (thick line) and a normal subject (thin line). The
ERG signals are 150-msec extracts. The L/M-cone–driven ERGs were
approximately in counterphase in the normal subject, mainly caused
by the counterphase stimulation of the L- and M-cones. The L/M-cone
tracings are from the same time windows of the recordings, enabling
a mutual comparison. Drift in the ERG responses to the L/M-cone–
isolating stimuli were suppressed by removing low-frequency compo-
nents. Patient 25, who had a mild phenotype carrying a 296insA
mutation in exon 3 and an A1038V mutation in exon 21, exhibited
reduced standard 30-Hz-fERG signals that were somewhat advanced
compared with the normal subject (A). His L-cone–driven ERG signal
was even larger and somewhat delayed compared with that of the
normal subject in (B), whereas his M-cone driven ERG signal was
considerably phase advanced and lower in amplitude (C).
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a normal distribution, making a standard test difficult. We
therefore converted the ratios into their logarithms that are
normally distributed. An unpaired t-test on these data did not
reveal a significant difference between the ratios in the patients
with SMD-FF and the control subjects.
Because of the large interindividual variability of L-/M-cone
weightings, neither of them can be directly used to quantify
the overall ERG sensitivity of individual patients. We therefore
quantified the mean maximal sensitivity (Sm) by determining
the theoretically least threshold defined as the smallest possi-
ble distance of the fitted ellipse to the origin. This smallest
possible distance can be estimated analytically from the model
fits.13 Bartlett’s F-test revealed that the variability of Sm in the
SMD-FF group was significantly larger than in the control group
(P 5 0.01; F 5 6.12). A subsequent Welch’s t-test (allowing a
comparison between groups with unequal SDs) revealed that,
on average, the Sm of the patients with SMD-FF (0.301 6 0.113
mV z [% cone contrast]21) did not differ significantly (P 5 0.4)
from that of the normal subjects (0.320 6 0.072 mV z [% cone
contrast]21; Fig. 4C).
To test for the relationship between Sm and other clinical
parameters (disease duration, visual acuity, central fundus
changes, distribution of flecks; Table 1), we used an analysis of
covariance (ANCOVA). To partial out the obvious dependency
of disease duration on age, we corrected disease duration for
age. In the ANCOVA, we tested a model in which it was
assumed that the variability in Sm can be explained by four
factors: age-adjusted disease duration, visual acuity, central
fundus changes, and distribution of flecks. Model fit was un-
satisfactory (adjusted R2 5 0.14; root mean square error 5 0.10
mV z [% cone contrast]21). Neither the age-adjusted disease
duration nor the other factors were significantly related to Sm.
Phases of Cone-Driven ERGs
The phases of the L/M-cone–driven ERGs were obtained di-
rectly from the Fourier analysis of the ERG responses to the
cone-isolating stimuli. In Figure 5, the ERG response phases for
the M- and L-cone–isolating stimuli are shown as a function of
cone contrast (provided that the response amplitudes were
significantly above noise level, typically being approximately
0.3 mV). As has been observed previously for normal sub-
jects,12,23 the ERG response phase lag decreased linearly with
increasing cone contrast for both subject groups within the
range of used cone contrasts (but see Reference 12 for the case
when low cone contrasts are included).
We applied an ANCOVA to these phase data to correct for
the influence of cone contrast. We assumed that the variability
in the data could be explained by four factors: subject group
(normal subjects, patients with SMD-FF), cone type, cone con-
trast, and subject number as a random effect. Further, it was
assumed that these factors could interact, that all measurement
errors were identical, and that there was a linear relationship
between response phase and cone contrast. As a result, four
different straight lines were estimated describing the relation-
ship between response phase and cone contrast for each sub-
ject group and each cone type by the ANCOVA (Fig. 5). Model
fit was good (adjusted R2 5 0.67; root mean square error 5
26.1°). Subject groups differed significantly (P 5 0.0038), and
there was a significant interindividual variability (P , 0.0001).
There were interactions between cone contrast and subject
group (P , 0.0001) and between cone contrast and cone type
(P , 0.0001). Nested groups defined by subject group and
cone type differed significantly (P , 0.0001).
The L-cone–driven ERG response phase lags decreased sig-
nificantly with increasing cone contrast with a slope of 1.62 6
0.36; P , 0.0001 in the normal subjects and a slope of 1.33 6
0.29; P , 0.0001 in the patients with SMD-FF. The M-cone–
driven ERG response phase lags also decreased with increasing
cone contrast with a slope (6SE) of 1.16 6 0.45 (P 5 0.01) in
the normal subjects and a slope of 0.50 6 0.40 in the patients
with SMD-FF, which was not significantly different from zero.
FIGURE 3. Threshold contrasts in
three normal subjects (A, left) and
nine patients with SMD-FF (B, right).
The ellipses are fits of a vector-addi-
tion model to the data points.10
There was a substantial interindi-
vidual variability for the phase differ-
ence between L/M-cone–driven ERG
responses in the patient group. In a
subset of the patients with SMD-FF
(lower three panels), the major axis
of the displayed ellipses is tilted to-
wards the first and third quadrant,
indicating phase differences that are
larger than 90°, resulting in a subtrac-
tive interaction between the signals
originating in the L-cones and the M-
cones. The mean maximal sensitivity
(quantified by the smallest possible
distance of the fitted ellipse to the
origin) was more variable in the pa-
tients with SMD-FF (indicated by the
different scaling used for two pa-
tients with SMD-FF).
1384 Scholl et al. IOVS, May 2001, Vol. 42, No. 6
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933221/ on 07/05/2017
From the ANCOVA, the mean ERG response phase, PL and
PM (at 17.5% cone contrast), was estimated for each combina-
tion of subject group and cone type. Post hoc tests (Tukey–
Kramer HSD; a 5 0.05) revealed that PL of the patients with
SMD-FF (2399°) lagged PL of the control subjects (2385°)
significantly and that PM of the patients (2323°) was signifi-
cantly phase advanced compared with the control group
(2376°). PL and PM differed significantly in the patients with
SMD-FF but not in the normal subjects (Fig. 6A). As a cause of
the differential effect of SMD-FF on PL and PM, the mean phase
difference of 76° (corresponding to 7.0 msec, when assuming
that a difference in time delay is causing the phase difference)
was considerably larger than the one in the normal subjects
(9°; corresponding to an 0.8-msec delay difference). Indepen-
dent estimates of the phase differences between L/M-cone–
driven ERGs (uPL 2 PMu) were available from the model fits to

FIGURE 4. (A) Estimated L-/M-cone weightings (AL and AM: means 6
SD) for the normal subjects and the patients with SMD-FF derived from
the fits of a vector-addition model to the threshold data. The results of
the ANOVA (post hoc tests) on the weighting data are displayed above
the histograms (*, significant difference; ns, nonsignificant effect). (B)
The L-/M-cone weighting ratio given as log(AL/AM) with mean 6 SE.
There was no significant difference between the normal subjects and
the patients with SMD-FF. (C) The maximal L/M-cone–driven ERG
sensitivity for the normal subjects and the patients with SMD-FF
(mean 6 SD). The SD in the SMD-FF group was significantly larger than
in the group of normal subjects (Bartlett’s F-test; P 5 0.01). Welch’s
t-test did not reveal a difference between the mean maximal sensitiv-
ities of the SMD-FF group and the control group.
FIGURE 5. ERG response phase to cone-isolating stimuli as a function
of cone contrast for the normal subjects and the patients with SMD-FF
(mean 6 SD). The response phases of the L-cone–driven ERGs were
delayed, whereas the phases of the M-cone–driven ERGs were ad-
vanced in the patients with SMD-FF compared with the normal sub-
jects. Four different straight lines describing the relationship between
response phase and cone contrast for each subject group and each
cone type were estimated with an ANCOVA.
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the threshold data and displayed in Figure 6B. uPL 2 PMu
differed significantly between patients and control subjects
(P 5 0.001; unpaired t-test).
Both measures correlated closely in both the control group
(r 5 0.82) and the SMD-FF group (r 5 0.86; Fig. 7). For the
combined groups, the correlation coefficient was 0.87 (95%
confidence interval, 0.77–0.92).
To test for the relationship between the clinical parameters
(age-adjusted disease duration, visual acuity, central fundus
changes, and distribution of flecks; Table 1) and uPL 2 PMu, an
ANCOVA was used. Model fit was satisfactory (adjusted R2 5
0.39; root mean square error 5 38.8°). However, only age-
adjusted disease was significantly correlated with uPL 2 PMu
(P 5 0.04).
Comparison of the L/M-Cone–Driven ERGs and
Color Vision Test
The majority of the patients with SMD-FF exhibited pro-
nounced color vision disturbances (Table 1). Ten patients
showed significant color vision disturbances with confusions
along a major axis. However, there was no obvious correlation
of the extent or the type of color vision with any of the values
derived from the L/M-cone–driven ERG measurements. None
of the patients had ERGs that were exclusively determined by
either L- or M-cone activity, as is described for patients with
dichromatism who have inherited red-green color vision de-
fects.10
Comparison of the L/M-Cone–Driven ERGs and
the Standard 30-Hz fERG
Sm, uPL 2 PMu were correlated with the amplitude and implicit
times of the 30-Hz fERG. The Bonferroni–Holm test was per-
formed to correct for multiple comparisons (multiple a 5
0.05). Sm correlated positively with the amplitude (r 5 0.67)
and negatively with the implicit time (r 5 20.38) of the 30-Hz
fERG. In addition, uPL 2 PMu correlated negatively with the
amplitude (r 5 20.39) and positively with the implicit time
(r 5 0.53) of the 30-Hz fERG. There was no significant corre-
lation between the logarithm of the L-/M-cone weighting ratio
and the two parameters of the 30-Hz fERG.
Mutation Analysis in the ABCA4 Gene
ABCA4 alterations were detected in 40 of the 45 patients
studied (Table 1). Two disease alleles were identified in 24
subjects including two affected brothers, whereas only a single
mutant allele was detectable in 16 patients (Table 1). Fifty
missense mutations made up the majority of the 64 ABCA4
alterations detected. In addition, seven nonsense mutations
were identified (five mutations affecting RNA splicing; two
single–base-pair insertions causing a frameshift), all of which
are considered to be moderate or severe alleles, because they
are expected to result in a truncated protein. Homozygosity for
a moderate or severe allele was not observed.
The numbers of occurrence of each present mutation were
too small to make any specific correlation between mutation
and clinical phenotype. In general, however, no obvious rela-
tionships were evident between the type of identified mutation
or its position within the gene and Sm or with uPL 2 PMu.
Similarly, no correlation was apparent between mutation type
and position with the presence and distribution of flecks or the
severity of fundus changes.
DISCUSSION
Correlation with Clinical Features
There is some controversy about whether there is a correlation
between funduscopically visible fundus changes and func-
tional abnormalities in SMD-FF. Classification of the fundus
changes has been controversial.24–27 We classified the patients
by two funduscopic criteria: the distribution of flecks (similar
to the classification of Hadden and Gass18) and the severity of
the central fundus changes. None of these measures, however,
correlated with the amplitude and phase features of the L/M-
cone–driven ERGs, which is in accordance with the findings of
FIGURE 6. (A) Phase data for the normal subjects and the patients with SMD-FF derived directly from the
ERG measurements with the cone-isolating stimuli (means 6 SE). After correction for the effect of cone
contrast, the phase lag of the L-cone–driven ERG response of the patients with SMD-FF was significantly
increased, whereas the M-cone–driven ERG phase lag was significantly decreased. The results of the
ANCOVA (post hoc tests) are indicated above the histograms (*, significant difference; ns, nonsignificant
effect). (B) Phase differences between L/M-cone–driven ERGs estimated from the fits of a vector-addition
model to the threshold data (means 6 SD). The fit data revealed a highly significant increase in phase
difference (P 5 0.001; unpaired t-test). This increase is in accordance with the changes in ERG response
phases obtained from the direct measurements.
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several studies using standard ERG techniques,24,28,29 but con-
tradicts others.25,30–32
Another matter of debate is whether functional abnormali-
ties are correlated with the disease duration. Noble and Carr24
did not find such a correlation. In contrast, Armstrong et al.32
found a significant correlation of ERG amplitudes and implicit
times with age-adjusted disease duration for the FF group but
not for the SMD group, whereas Moloney et al.28 found the
opposite. We found uPL 2 PMu to be significantly correlated
with duration, but not the overall ERG sensitivity Sm. This may
suggest that uPL 2 PMu and Sm represent two independent
disease processes. OnlyuPL 2 PMuappears to be a useful mea-
sure for evaluating the disease and monitoring its progression.
The fact that there was no correlation between the color
vision disturbances and the ERG data is not surprising, because
color vision tasks such as the Lanthony D-15 desaturated test
represent psychophysical measurements exclusively testing
the macula. The data of our ERG measurements, however,
reflect the function of a much larger part of the retina. Fur-
thermore, we recently established that the processing of cone
signals in the chromatic channel and in the ERG is mutually
independent.21 A change in the ERG is probably also indepen-
dent of changes in the chromatic channel.
Correlation with Genotype
It has been proposed that residual ABCA4 protein activity
determines the clinical phenotype of SMD-FF and other related
retinal diseases, whereas the pairing of two null or severe
mutations is thought to lead to a more severe phenotype
resembling a cone–rod dystrophy or inverse RP.33–35 The mu-
tation profile in our group of patients with SMD-FF (with two
identified mutations) is in concordance with this model, be-
cause only a combination of a mild and severe mutation (e.g.,
G1961E and 296insA) or of two moderate mutations (e.g.,
IVS4015G3A and A1038V) were encountered, whereas the
pairing of two null or severe mutations was not observed in our
patient sample. Within the patient group, however, no pheno-
typic distinctions associated with genotype were apparent. We
did not find an association between mutation type and the
presence of flecks or severity of fundus changes, nor did we
note any association with the functional alterations.
Correlation with Standard ERG Techniques
Several groups have investigated the amplitudes and implicit
times of the photopic standard ERG in SMD-FF with differing
results.18,24–32,36 Recently, we argued that the 30-Hz fERG can
be misinterpreted, because its amplitude depends not only on
overall ERG sensitivity (Sm) but also on the phase difference
between the L/M-cone–driven ERG (uPL 2 PMu).
13 This hypoth-
esis is now statistically validated in the large group of patients
with SMD-FF. Moreover, because the phase changes are differ-
ent for the L/M-cone–driven ERGs, the amplitudes rather than
the implicit times of the 30-Hz fERG reveal the actual timing
changes within the individual cone pathways. Thus, the 30-Hz
fERG is a signal that depends in a complex manner on its
constituent components and is therefore difficult to interpret.
Origins of Selective Changes of
L/M-Cone–Driven ERGs
It has been found that in SMD-FF the ABCA4 gene is defective,
resulting in a change in the rod ABCA4 (rim protein), which is
involved in the regeneration of rhodopsin.37,38 These findings
are in accordance with the observation that patients with
SMD-FF show rod deficits.25,39,40 In addition, Molday et al.9
showed that ABCA4 is present in both cone and rod photore-
ceptors, suggesting that it is involved in the photopigment
regeneration of both photoreceptor types.
It remains speculative to link these molecular findings with
the functional alterations of the L/M-cone–driven ERG path-
ways. The change in the cone ERGs are possibly caused by
either a change within the cones themselves, due to the de-
fective ABCA4, or are the indirect result of an alteration within
the RPE. However, it is difficult to conceive how any of these
changes might lead to selective modification in the L/M-cone–
driven ERG.
Recently, we found similar timing changes in patients with
RP.13 The phase difference between L/M-cone–driven ERGs
was substantially increased. Some patients with SMD-FF (e.g.,
patients 17 and 87 in Fig. 3) showed similar phase differences.
Because RP primarily affects the rod system, and the cone
system is only secondarily affected, similar secondary cone
alterations after primary rod modifications in SMD-FF cannot be
excluded.
It is well established that the ERG at 30 Hz is the result of
postreceptoral mechanisms, most probably at the bipolar cell
level, involving both ON- and OFF-responses.41 A selective
FIGURE 7. Phase differences between L/M-cone–driven ERG re-
sponses obtained from the direct measurements as a function of the
phase differences obtained from the model fits to the threshold data for
individual normal subjects and patients with SMD-FF. For the direct
measurements, ERG response phases at 24.7% L-cone contrast and
23.4% M-cone contrast data were considered. (Response phases at
similar cone contrasts were used to minimize contamination by the
influence of cone contrast.) The fits provided only absolute values of
phase differences and therefore are not conclusive about which cone
response was leading. The authors decided to give the phase differ-
ences calculated from the model fits the same sign as those obtained
from the direct measurements: Positive-phase differences indicate that
the M-cone–driven ERG responses were leading; negative-phase differ-
ences indicate that the L-cone–driven ERG responses were leading (see
also Fig. 6 in Kremers et al.10). The description of the linear regression
describing the relationship between the two values is given in the
legends. For both the patients with SMD-FF (r 5 0.86; P , 0.0001) and
the normal subjects (r 5 0.82; P , 0.0001), the two regressions had
very similar slopes, but larger phase differences were observed in a
subset of the patients with SMD-FF.
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change in the ON- and OFF-components of the L/M-cone–
driven ERGs may also lead to the described pattern in the
patients with SMD-FF. However, on the basis of our data it is
impossible to draw a definite conclusion on the responsible
pathologic mechanism.
Are Temporal Alterations of L/M-Cone–Driven
ERG Pathways a General Feature of
Retinal Dystrophies?
Recently, we found large phase differences between the L/M-
cone–driven ERGs in patients with RP13 and to a lesser extent
in patients with Best’s macular dystrophy (BMD).42 In the
present report, we describe similar alterations in a large group
of genetically screened patients with SMD-FF suggesting that
such different alterations of the L/M-cone pathways indeed are
a general feature of retinal dystrophies.
However, there are substantial differences between patients
with RP and those with SMD-FF when both the amplitude and
the timing data are taken into consideration. Furthermore, the
dependency of the response phases on cone contrast seems to
be different between different patient groups. The mean M-
cone–driven ERG response phase PM was significantly phase
advanced in patients with SMD-FF (2323°), patients with RP13
(2326°), and patients with BMD42 (2345°) when compared
with normal subjects (2376°). The mean L-cone driven ERG
phase PL was significantly phase delayed in patients with
SMD-FF (2399°) and in patients with RP13 (2486°), whereas
PL of the patients with BMD did not show a significant differ-
ence from that of normal subjects42 (2383° and 2385°, re-
spectively). The mean L/M-cone–driven ERG sensitivity Sm,
however, was normal in the patients with SMD-FF as a group
(0.301 mV z [% cone contrast]21) compared with that in normal
subjects (0.320 mV z [% cone contrast]21), whereas Sm was
significantly decreased in patients with RP13 (0.151 mV z [%
cone contrast]21) and significantly increased in those with
BMD42 (0.493 mVz [% cone contrast]21). Furthermore, in nor-
mal subjects,10,12 patients with BMD,42 and patients with SMD-
FF, both the L- and the M-cone–driven ERG phases are posi-
tively correlated with cone contrast, whereas in most patients
with RP, there is a negative correlation.13 We conclude that
L/M-cone–driven ERGs can serve as a tool for a differential
diagnosis of hereditary retinal disorders when both amplitude
and phase criteria are considered.
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